Inhibition of tissue-thromboplastin-induced thrombin generation in primates by DX-9065a, a specific factor Xa inhibitor

被引：0
|
作者：
Fukuda, T
Morishima, Y
Hara, T
Kunitada, S
机构：
[1] Daiichi Pharmaceut Co Ltd, New Prod Res Labs 2, Tokyo, Japan
[2] Daiichi Pharmaceut Co Ltd, New Prod Res Labs 3, Tokyo, Japan
来源：
THROMBOSIS AND HAEMOSTASIS | 1999年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
596
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [21] Factor Xa inhibition by DX-9065a improved mortality and organ failure following endotoxin-induced sepsis in rats
    Hara, T
    Fujiwara, K
    Kunitada, S
    THROMBOSIS AND HAEMOSTASIS, 1999, : 190 - 191
  • [22] SELECTIVE FACTOR XA INHIBITOR, DX-9065A, SUPPRESSED HYPERCOAGULABLE STATE DURING HEMODIALYSIS IN CYNOMORGUS MONKEYS
    HARA, T
    MORISHIMA, Y
    KUNITADA, S
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1311 - 1311
  • [23] Synthetic inhibitor for coagulation factor Xa (DX-9065a) does not exert a serious influence on thrombin forming time, but affects total thrombin activity.
    Ieko, M
    Takeda, M
    Naitoh, S
    Nakabayashi, T
    Sawada, K
    Koike, T
    BLOOD, 2001, 98 (11) : 73B - 73B
  • [24] PROLONGATION OF COAGULATION TIME DUE TO THE INHIBITION OF FACTOR-XA BY DX-9065A, AN ORALLY-ACTIVE SYNTHETIC ANTICOAGULANT SPECIFIC FOR FACTOR-XA
    ISHIHARA, H
    HARA, T
    YOKOYAMA, A
    NAGAHARA, T
    IWAMOTO, M
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 671 - 671
  • [25] SPECIES-DIFFERENCES IN ANTICOAGULANT AND ANTI-XA ACTIVITY OF DX-9065A, A HIGHLY SELECTIVE FACTOR XA INHIBITOR
    HARA, T
    YOKOYAMA, A
    MORISHIMA, Y
    KUNITADA, S
    THROMBOSIS RESEARCH, 1995, 80 (01) : 99 - 104
  • [26] A specific inhibitor of factor Xa, DX-9065a, exerts effective protection against experimental tumor-induced disseminated intravascular coagulation in rats
    Tanabe, K
    Terada, Y
    Shibutani, T
    Kunitada, S
    Kondo, T
    THROMBOSIS RESEARCH, 1999, 96 (02) : 135 - 143
  • [27] Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats
    Yamazaki, M
    Asakura, H
    Aoshima, K
    Saito, M
    Jokaji, H
    Uotani, C
    Kumabashiri, I
    Morishita, E
    Ikeda, T
    Matsuda, T
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1996, 22 (03): : 255 - 259
  • [28] Antithrombotic and hemorrhagic effects of DX-9065a, a direct and selective factor Xa inhibitor: Comparison with a direct thrombin inhibitor and antithrombin III-dependent anticoagulants
    Morishima, Y
    Tanabe, K
    Terada, Y
    Hara, T
    Kunitada, S
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (05) : 1366 - 1371
  • [29] Tolerability, pharmacokinetics, and pharmacodynamics of DX-9065a, a new synthetic potent anticoagulant and specific factor Xa inhibitor, in healthy male volunteers
    Murayama, N
    Tanaka, M
    Kunitada, S
    Yamada, H
    Inoue, T
    Terada, Y
    Fujita, M
    Ikeda, Y
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (03) : 258 - 264
  • [30] IN-VIVO EVALUATION OF DX-9065A, A SYNTHETIC FACTOR-XA INHIBITOR, IN EXPERIMENTAL VEIN GRAFT MODEL
    KIM, DI
    KAMBAYASHI, J
    SHIBUYA, T
    KAWASAKI, T
    SHIBA, E
    SAKON, M
    MORI, T
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 672 - 672
12345